Placebo Effect Hinders Quality Of Chronic Pain Treatment Trials – FDA, CMS
This article was originally published in The Gray Sheet
Executive Summary
Chronic pain therapy manufacturers must meet challenges presented by the placebo effect when designing clinical trials, according to FDA and CMS